Search Share Prices
AZN Headlines - Chronic Kidney Disease Drugs Market Expected to Grow at a CAGR of 4.5% by 2027
Research Nester released a report titled "Chronic Kidney Disease Drugs Market: Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global chronic kidney disease ...
UBS Group Analysts Give AstraZeneca PLC (AZN.L) (LON:AZN) a GBX 7,500 Price Target
AstraZeneca PLC (AZN.L) (LON:AZN) has been given a GBX 7,500 ($97.99) price objective by analysts at UBS Group in a research note issued to investors on Wednesday, Borsen Zeitung reports. The ...
People with severe allergies told to avoid Pfizer/BioNTech vaccine after two NHS workers have reaction
People with severe allergies have been told not to receive the new Pfizer/BioNTech COVID-19 vaccine after two health workers fell ill after getting the jab. Britain started mass vaccinations yesterday ...
AstraZeneca PLC (AZN.L) (LON:AZN) Given a GBX 9,900 Price Target by Morgan Stanley Analysts
AstraZeneca PLC (AZN.L) (LON:AZN) received a GBX 9,900 ($129.34) price objective from equities researchers at Morgan Stanley in a report released on Monday, Borsen Zeitung reports. The firm currently ...
AstraZeneca PLC (AZN.L) (LON:AZN) Given a GBX 9,900 Price Target at Morgan Stanley
Morgan Stanley set a GBX 9,900 ($129.34) price target on AstraZeneca PLC (AZN.L) (LON:AZN) in a research note issued to investors on Monday morning, Borsen Zeitung reports. The firm currently has a ...